Oral Quinidine Therapy for the Maintenance of Sinus Rhythm After Mitral Valve Surgery

승모판 수술후 동율동 유지에 대한 Quinidine의 효과

  • Published : 1993.04.01

Abstract

Atrial fibrillation is commonly associated with organic mitral valve disease including rheumatic valvular heart diasease or mitral valve prolapse and so forth. Although spontaneous sinus reversion may occur in some patients after mitral valve operation, recurrence of atrial fibrillation is the rule in most of these patients. We have tried to maintain sinus rhythm after mital valve operation with oral quinidine therapy, and we will show the efficacy of this therapy in this report. From January 1986 to August 1992, 60 patients of mitral valvular heart disease, who had had atrial fibrillation preoperatively and gained sinus rhythm postoperatively, were selected for this study. These patients were divided into 2 groups: Control group [n=30] and Quinidine trial group [n=30]. The age,sex, duration of symptoms,left atrial size and other risk factors of the reversion to atrial fibrillation were adjusted to be similar between the two groups. The maintenance rate of sinus rhythm was calculated by Kaplan-Meier method, and the rate was significantly higher in quinidine trial group than in control group [ p=0.0001 ]. Univariate analysis was performed on the risk factors of reversion to atrial fibrillation, and the difference of maintenance rate between the two groups were corrected with this result: the difference was still statistically significant [ p=0.0205 ]. The quinidine levels were measured in postoperative days, and there were no difference of serum quinidine level between the quinidine success group and quinidine failure group. In conslusion, oral quinidine therapy was effective for the maintenance of sinus rhythm after mitral valve operation compared to control group, and there was no correlation between the serum quinidine level and clinical efficacy of quinidine therpy.

Keywords

References

  1. J Thorac Cardiovasc Surg v.99 Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillatioon after cardiac operation McAlister,H.F.;Luke,R.A.;Whitlock,R.M.;Smith,W.M.
  2. 대흉외지 v.17 심장판막치환환자의 심전도적 술후추적 김종환
  3. Am J Cardiol v.26 Pharmacodynamics and clinical use of cardiocascular drugs after cardiac surgery Harrison,D.C.;Kerber,R.E.;Alderman,E.L.
  4. Ann Intern Med v.93 Les Torsades de pointes:an unusual ventricular arrhythmia Smith,W.M.;Gallagher,J.J.
  5. Am Heart J v.111 Incidence and clinical feature of the quinidine-associated long QT syndrome:Implications for patient care Roden,D.M.;Woosley,R.L.;Primm,R.K.
  6. Clin Pharm v.5 Digoxin prophylaxis following coronary artery bypass surgery Weiner,B.;Rheinlander,H.F.;Decker,E.L.;Cleveland,R.J.
  7. Circulation v.32 The incidence and management of medical complication following cardiac operations Williams,J.F.;Morrow,A.G.;Braunwald,E.
  8. Isr J Med Sci v.5 Early conversion of atrial fibrillation after open-heart surgery by combined proplanolol and quinidine treatment Stern,S.;Borman,J.B.
  9. Aust NZ J Med v.15 Atrial tachyarrhythmia after cardiac surgery:results of disopyramide therapy Gavaghan,T.P.;Feneley,M.P.;Campbell,T.J.;Morgan,J.J.
  10. Aust NZ J Med v.10 Treatment of atrial arrhythmias after cardiac surgery with intravenous disopyramide Campbell,T.J.;Morgan,J.J.
  11. J Thorac Cardiovasc Surg v.81 Intravenous amiodarone in the treatment of various arrhythmia following cardiac operations Installe,E.;Schoevaerdts,J.C.;Gadisseux,P.H.;Charles,S.;Tremouroux,J.
  12. Clin prog Electrophysiol Pacing v.4 Intravenous amiodarone:emodynamics, pharmacokinetics, eletrophysiology, and clinical utility Mostow,N.D.;Vrobel,T.R.;Noon,D.;Rakita,L.
  13. Am J Cardiol v.53 Effect of amiodarone of serum quinidine and procainamide levels Saal,A.K.;Werner,J.A.;Greene,H.L.;Sears,G.K.;Graham,E.L.
  14. Aust NZ J Med v.15 Atrial tachyarrhythmia after cardiac surgery:results of disopyramide therapy Gavaghan,T.P.;Feneley,M.P.;Campbell,T.J.;Morgan,J.J.
  15. J Thorac Cardiovasc Surg v.82 Open mitral valvotomy:effect of preoperative factors of result Smith,W.M.;Neutze,J.M.;Barratt Boyes,B.G.;Lowe,J.B.
  16. Br Heart J v.54 Intravenous soltalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass:comparison with disopyramide and digoxin in a randomised trial Campbell,T.J.;Gavaghan,T.P.;Morgan,J.J.
  17. J Thorac Cariovasc Surg v.81 Prevention of supraventricular tachyrrythmia with low-dose proplanolol after coronary bypass Mohr r;Smolinsky,A.;Goor,D.A.
  18. J Thorac Cardiovasc Surg v.89 Arrhythmia prophylaxis after aorta-coronary bypass:effect of mini-dose proplanolol Matangi,M.F.;Neutze,J.M.;Graham,K.J.;Hill,D.G.;Kerr Ar;Barratt Boyes,B.G.
  19. J Thorac Cardiovasc surg v.83 Verapamil therapy of atrial fibrialltion and atrial flutter following cardiac operation Plumb,V.J.;Karp,R.B.;Kouchoukos,N.T.;Zorn,G.L.;James,T.N.;Waldo,A.L.
  20. Int J Cardiol v.9 Oral verapamil fails to prevent supraventricular tachycardias following coronary artery bypass graft surgery Smith,E.E.;Shore,D.F.;Monro,J.L.;Ross,J.K.